MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cellsZhan Wang, Weibing Zhou|Oncology Reports|2019Cited by 19
389P Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trialHan Li, Zhi Shi, Z. Yv et al.|Annals of Oncology|2024Cited by 0